XML 32 R18.htm IDEA: XBRL DOCUMENT
v3.26.1

Net Income Per Share | 3 Months Ended
--- | ---
Mar. 31, 2026
Net Income Per Share |
Net Income Per Share | 10. Net Income Per Share Basic net income per share is computed by dividing net income by the weighted-average number of common shares outstanding during the period, reduced by unvested restricted stock awards. As of both March 31, 2026 and April 1, 2025, an aggregate of 3.2 million and 3.3 million shares, of restricted stock and restricted stock units issued were unvested, respectively, and, therefore, excluded from the calculation of basic earnings per share for the fiscal periods ended on those dates. Diluted net income per share is computed by dividing net income by the weighted-average number of common stock equivalents outstanding for the period. Common stock equivalents for the 2026 Notes and 2030 Notes are determined by application of the if-converted method, and common stock equivalents for outstanding stock options, restricted stock and restricted stock units are determined by application of the treasury stock method. ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Thirteen | ​ | Thirteen
​ | ​ | Weeks Ended | ​ | Weeks Ended
​ | ​ ​ ​ | March 31, 2026 | ​ ​ ​ | April 1, 2025
​ | ​ | (In thousands, except per share data)
Net income | ​ | $ | 49,548 | ​ | $ | 32,941
​ | ​ | ​ | ​ | ​ | ​ | ​
Basic weighted-average shares outstanding | ​ | ​ | 46,585 | ​ | ​ | 47,526
Dilutive effect of equity awards (1) | ​ | ​ | 1,870 | ​ | ​ | 1,758
Diluted weighted-average shares outstanding | ​ | ​ | 48,455 | ​ | ​ | 49,284
​ | ​ | ​ | ​ | ​ | ​ | ​
Basic net income per share | ​ | $ | 1.06 | ​ | $ | 0.69
​ | ​ | ​ | ​ | ​ | ​ | ​
Diluted net income per share | ​ | $ | 1.02 | ​ | $ | 0.67
(1) | Shares of common stock equivalents related to outstanding stock options, restricted stock and restricted stock units of 0.6 million and 0.8 million for March 31, 2026, and April 1, 2025, respectively, were excluded from the diluted calculation due to their anti-dilutive effect. No shares of common stock equivalents related to the 2026 Notes or 2030 Notes were included in the diluted calculation due to their anti-dilutive effect.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration